Brian Lortie, president and CEO at Uniquity Bio, offered up key insights on building teams, securing capital, and operating with efficiency during a recent Business of Biotech podcast recording.

US pharma giant Merck & Co has started building a $1 billion, 470,000-square-foot biologics center of excellence in ...

In this week’s edition of InnovationRx, we look at a patent fight over the world’s top-selling drug, breakthroughs from the American Association for Cancer Research, Verily’s Parkinson’s dataset, the ...

The Michael Davis-led Delaware Rock and Roll Hall of Fame rockabilly act The Bullets have a weekly residency at Gallucio's Italian Restaurant in Wilmington on Thursday nights.

This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free daily Manufacturing Dive newsletter. Merck is constructing a $1 billion drug ...

NEWARK- QPS Holdings, LLC, a global clinical research organization (CRO) headquartered in Newark, is expanding its presence ...

There have been some memorable late call-ups. Sam Bennett got a knee injury before the 2021 Tour de France and so Mark ...

Merck is going all-in on domestic drug manufacturing with a $1 billion Delaware facility aimed at dodging Trump-era tariff ...

Albert Bourla said Pfizer is being "frugal" with investments because of the uncertainty surrounding tariffs.

The pharmaceutical giant will invest $1 billion in a Delaware plant to manufacture Keytruda, as drugmakers ramp up U.S.

Merck starts construction on a $1B biologics facility in Wilmington, Del., expected to create 500+ jobs and support Keytruda production.